NCT00686036 2016-12-21
ZENITH
Sanofi
Phase 2 Terminated
Clinical Trials
3 trialsNCT00498797 2016-10-07
E3-Hormone Refractory Prostrate Cancer Taxotere Combination
Sanofi
Phase 2 Completed
NCT00757692 2013-02-20
Efficacy and Safety Study of Vandetanib (ZD 6474) in Combination With Bicalutamide Versus Bicalutamide Alone in Patients With Chemotherapy Naive Hormone Refractory Prostate Cancer.
British Columbia Cancer Agency
Phase 2 Completed